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Summary
Focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2) are related tyrosine kinases that have important cellular functions,
primarily through regulation of the cytoskeleton. Recent studies have identified multiple molecular mechanisms that regulate cytoskeletal
responses, and have provided important and exciting insights into how FAK and Pyk2 control cellular processes such as cell migration.
Equally exciting are reports of novel and originally unanticipated functions of these kinases, providing the groundwork for future
avenues of investigation. This Commentary summarizes some of these recent discoveries that are relevant to the control of biological
responses of the cell.
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Introduction
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine
kinase that plays an essential role during embryonic development
and in the pathogenesis of human disease, including cancer and
cardiovascular disease (Golubovskaya et al., 2009a; Vadali et al.,
2007). FAK is expressed in most tissues and its sequence is highly
conserved across species. The mouse (97% identity) and frog (90%
identity) protein sequences are highly related in sequence to human
FAK, and the zebrafish protein is conserved as well (79% identity).
Sequence and structural analysis reveals four distinct domains within
FAK: an N-terminal FERM domain; a centrally located catalytic
tyrosine kinase domain; a C-terminal focal-adhesion targeting
(FAT) domain (a four-helix bundle); and an unstructured prolinerich region between the catalytic and FAT domains (Fig. 1). The
FERM domain docks with the catalytic domain to autoinhibit kinase
activity, but also interacts with other molecules to control FAK
signaling. The FAT domain and proline-rich region are also docking
sites for binding partners that function in localization and
downstream signaling (Fig. 1). Proline-rich tyrosine kinase 2
(Pyk2) is related to FAK in sequence (46% identical and 65%
similar, at the protein level) and structure, but is a nonessential gene.
Its tissue expression is more restricted compared with that of FAK.
Pyk2 shares the four-domain organization with FAK.
FAK expression is required in several tissues for normal
development. In endothelial cells, FAK is required for embryonic
angiogenesis and FAK expression is necessary for proper
development of the heart (Braren et al., 2006; Hakim et al., 2007;
Shen et al., 2005). In the adult heart, FAK plays a role in the
hypertrophic response, although its precise function has not been
resolved (DiMichele et al., 2006; Peng et al., 2006). In neurons,
FAK functions downstream of netrins to promote neurite outgrowth
and axon guidance (Li et al., 2004; Liu et al., 2004; Ren et al.,
2004). FAK is overexpressed (but not mutated) in a number of
human malignancies and many lines of investigation support a role
for FAK in the development of human cancer (Golubovskaya
et al., 2009a). Analysis of Pyk2-knockout mice reveals a role for
this kinase in macrophages and osteoclasts (Gil-Henn et al., 2007;

Okigaki et al., 2003). There is also some evidence suggesting that
Pyk2 might control some phenotypes of cancer cells.
FAK responds to extracellular stimuli, including signals from the
extracellular matrix (ECM), and regulates cellular processes such
as proliferation and cell migration (Mitra et al., 2005). Alterations
in these cellular processes are the key events associated with the
development and progression of disease. This article focuses on
recent findings about the mechanisms used by FAK to control
cellular events; selected older findings are only included for context.
Topics covered include advances in understanding established
functions of FAK (e.g. control of the actin cytoskeleton and
adhesion) and emerging functions of FAK (e.g. regulating
microtubules and mitosis), and the identification of unanticipated
FAK functions (e.g. in the nucleus). A second theme of the article
is a comparison of FAK and Pyk2 function in controlling cellular
events. Not surprisingly, some functions are shared, but the two
kinases can be regulated differently, even in response to the same
stimulus, and a similar biological endpoint can be reached by both
kinases through distinct mechanisms.
FAK and cell migration
New developments in an old story

FAK has long been known as a regulator of cell migration. In most
experimental systems [but not all (Yano et al., 2004)], enhanced
FAK signaling promotes cell motility, whereas inhibition of FAK
signaling through a variety of approaches impairs cell migration
(Mitra et al., 2005). FAK functions in controlling motility in
randomly migrating cells and in response to a broad range of stimuli,
including chemotactic, haptotactic and durotactic signals. In the
simplest terms, the cell must perform three tasks to migrate: first,
it must decide where it wants to go (and this applies to even
randomly migrating cells); second, cells must generate protrusive
activity at the leading edge to move; and third, cells must retract
the trailing edge to achieve net migration. FAK has now been
implicated as functioning in all three of these tasks (Fig. 2).
In a wounded monolayer of cells in culture, cells at the edge of
the wound re-orient and polarize, which is measured by
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Fig. 1. Molecular structure of FAK. The major domains of FAK (FERM, kinase and FAT domains) are shown. The boundaries of the three subdomains (F1, F2
and F3) of the FERM domain are illustrated. Putative nuclear export sequences (NESs) and the nuclear localization sequence (NLS) are indicated. Regions of FAK
implicated in mediating intramolecular and intermolecular protein interactions are also shown.

relocalization of the Golgi to the side of the nucleus closest to the
wound. There is some evidence suggesting that this event is
important for directional motility into the wound; perturbation of
proteins whose primary function is regulation of Golgi structure
alters relocalization of the Golgi and impairs cell migration in
a wound-healing assay (Yadav et al., 2009). Whether this is a
universal event associated with directional motility is clearly
questionable, as there is no correlation between Golgi location and
direction of movement in randomly migrating fibroblasts (Uetrecht
and Bear, 2009). Regardless, there is a defect in relocalization of
the Golgi in wounded monolayers of cells lacking FAK (Tilghman
et al., 2005; Tomar et al., 2009). In the absence of FAK, cells at
the edge of the wound fail to form prominent lamellipodia that
protrude into the wound. Interestingly, Pyk2 also functions in
controlling cell polarization; macrophages that lack Pyk2 are
defective in establishing a polarized morphology in response to a
chemotactic stimulus (Okigaki et al., 2003). These findings show
a role for FAK and Pyk2 in the establishment of cell polarity in
response to a stimulus to migrate (Fig. 2).
Time-lapse video microscopy of individual cells migrating in two
dimensions reveals a defect in directional persistence in cells with
impaired FAK function (Owen et al., 2007; Wang et al., 2001).
Analysis of lamellipodial behavior in macrophages lacking FAK
reveals increased protrusion and retraction of lamellipodia, but
defective persistence compared with wild-type macrophages (Owen
et al., 2007). Pyk2 also functions in the control of macrophage
motility; Pyk2-null cells also exhibit migration defects (Okigaki
et al., 2003). Inhibition of FAK or Pyk2 expression in macrophages
impairs colony-stimulating factor-1 (CSF-1)-induced invasion by
about 60%, but simultaneous inhibition of the expression of both
does not inhibit invasion further (Owen et al., 2007). Thus,
both FAK and Pyk2 are required for invasion and, in this scenario,
appear to function non-redundantly. These studies demonstrate a
role for FAK and Pyk2 in controlling macrophage migration, and
a role for FAK in regulating events at the leading edge of migrating
cells (Fig. 2).
There is also evidence that FAK functions at the trailing edge of
the cell to control tail retraction. In wild-type fibroblasts treated
with lysophosphatidic acid (LPA), focal adhesions at the rear are
pulled forward as the cell moves (perhaps preceding disassembly).
By contrast, in cells with impaired FAK expression owing to RNAibased knockdown, focal adhesions at the rear of cells are stable
(Iwanicki et al., 2008). In some scenarios, for example, in FAKnull fibroblasts, Pyk2 can compensate to promote normal cell
retraction. Elimination of Pyk2 expression under these
circumstances dramatically impairs tail retraction (Lim et al.,

2008b). Pyk2-null macrophages also exhibit a defect in tail retraction
in response to a chemotactic stimulus (Okigaki et al., 2003). These
studies demonstrate a role for FAK and Pyk2 at the trailing edge
of motile cells (Fig. 2).
FAK and the actin cytoskeleton
Regulation of Rho family proteins – multiple mechanisms

As described above, FAK has a role in regulating cell migration,
but what are the molecular mechanisms that are used by FAK to
control these cellular responses? One established FAK-dependent
mechanism controlling cell migration is regulation of the
disassembly of focal adhesions (Ren et al., 2000; Webb et al., 2004).
At the rear of the cell, FAK is required for the forward movement
of focal adhesions and presumably subsequent disassembly to allow
tail retraction (Iwanicki et al., 2008); at the leading edge of the cell,
FAK is required for the efficient disassembly of adhesions and also
for the assembly of adhesions (Owen et al., 2007) (Fig. 2). One
potential mechanism regulating adhesion assembly is regulation of
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] generation at
sites of adhesion (Ling et al., 2002), which in turn could regulate
talin-dependent activation of integrin-ligand binding (Nayal et al.,
2004). Other studies exploring the mechanism of regulation of
cytoskeletal events by FAK and Pyk2 have focused on the regulation
of Rho family proteins.
FAK-null fibroblasts exhibit elevated levels of active Rho (Ren
et al., 2000). In macrophages, the absence of FAK leads to a modest
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Fig. 2. Major cellular functions of FAK. A migrating cell with the leading
edge (right) and trailing edge (left) is shown. Cell-ECM adhesions (red), stress
fibers (green), microtubules (dark blue), the MTOC (grey) and nucleus (blue)
are illustrated. Black lines denote cellular targets of FAK signaling.
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increase in Rac activity (Owen et al., 2007). By contrast, Pyk2-null
macrophages exhibit a defect in Rho activation in response to
chemokines (Okigaki et al., 2003). The role of Pyk2 in controlling
Rho activity is clearly context dependent, as Pyk2-null osteoclasts
exhibit the opposite phenotype: an increase in Rho activity (GilHenn et al., 2007). Thus, there appear to be signal-dependent and/or
cell-type-dependent mechanisms regulating Rho activity
downstream of Pyk2.
Multiple mechanisms are employed by FAK to regulate the
activation status of Rac and Rho (Fig. 3). A GTPase-activating
protein (GAP) called GRAF (GTPase regulator associated with
FAK) binds to the C-terminal domain of FAK and associates
with Pyk2 as well (Hildebrand et al., 1996; Ohba et al., 1998).
Whereas GRAF promotes hydrolysis of GTP bound to both Rho
and Cdc42 in vitro, expression of GRAF in cells blocks the actincytoskeleton changes that are associated with Rho activity
(formation of stress fibers) and does not affect filopodia formation,
which is dependent on Cdc42 activity. This suggests a more
restricted substrate specificity in vivo (Taylor et al., 1999). A second
GAP that binds FAK and Pyk2 is PSGAP (PH- and SH3-domaincontaining RhoGAP protein) (Ren et al., 2001). PSGAP promotes
hydrolysis of GTP bound to both Rho and Cdc42 in vitro and in vivo.
Interestingly, Pyk2, but not FAK, can phosphorylate PSGAP to
impair GAP activity towards Cdc42 (Ren et al., 2001). This
suggests different modes of signaling, whereby FAK recruits
PSGAP to impair Rho and Cdc42 signaling, and Pyk2
recruits PSGAP for phosphorylation and inhibition of its activity,
thus promoting Cdc42 activity. The roles of GRAF and PSGAP in
regulating the cytoskeletal events that are controlled by FAK and
Pyk2 have not been fully explored. A third GAP, p190RhoGAP,
can be recruited into a complex with p120RasGAP and FAK at
focal adhesions (Tomar et al., 2009). Both p190RhoGAP and
p120RasGAP function in controlling FAK-dependent cytoskeletal
changes, as they are both required for proper polarization of cells
at the edge of a wound (Tomar et al., 2009).
FAK and Pyk2 also associate with regulatory proteins that
promote the activation of Rho family signaling (Fig. 3). FAK binds

Rac

Cdc42

the Rho-activating guanine-nucleotide exchange factor (GEF)
PDZRhoGEF, which colocalizes with FAK (Iwanicki et al., 2008).
Impairing PDZRhoGEF using a short hairpin RNA (shRNA)
approach retards the movement of focal adhesions at the rear of
the cell. Expression of exogenous PDZRhoGEF overcomes the
defect in the movement of adhesions in cells caused by perturbing
FAK expression (Iwanicki et al., 2008). Thus, PDZRhoGEF
appears to function with FAK to promote the forward movement
of focal adhesions at the rear of migrating cells. FAK also
associates with a second exchange factor, p190RhoGEF (Lim et al.,
2008b; Zhai et al., 2003). A fraction of p190RhoGEF localizes to
focal adhesions, and it also appears to function in conjunction with
FAK to control focal-adhesion turnover and migration (Lim et al.,
2008b). A mutant of p190RhoGEF that is defective for FAK
binding exhibits impaired biological activity, supporting a role for
p190RhoGEF in controlling FAK-dependent cytoskeletal responses
(Lim et al., 2008b). Pyk2 can also bind to p190RhoGEF to promote
Rho activation. The mechanism is slightly different, however, as
FAK-p190RhoGEF localization to focal adhesions is important for
function, whereas localization of Pyk2-p190RhoGEF to focal
adhesions is not required (Lim et al., 2008b). Based on these recent
findings that RhoGEFs and RhoGAPs associate with FAK and
function in the control of cytoskeletal changes downstream of FAK,
the intriguing hypothesis that FAK might alternately control the
activation and inactivation of Rho was recently suggested (Tomar
and Schlaepfer, 2009).
Recent studies demonstrate that FAK might function in
the regulation of cytoskeletal events through the modulation of the
paxillin kinase linker (PKL/Git2)–b-pix complex (Fig. 3). b-pix is
an exchange factor for Cdc42 that also functions as a scaffold to
promote signaling via Rac and PAK (Frank and Hansen, 2008).
Thus, b-pix potentially functions to coordinate Cdc42 and Rac
signaling. At the cellular level, b-pix is an important regulator of
the polarity of migrating cells and lamellipodia formation (Frank
and Hansen, 2008). PKL/Git2 targets b-pix to focal adhesions
through binding to paxillin (Turner et al., 1999). FAK regulates
tyrosine phosphorylation of b-pix, which in turn regulates the
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Fig. 3. Networks of FAK signaling that control the actin cytoskeleton and gene expression. Solid lines link proteins that physically interact and dashed lines
denote indirect protein-protein interactions. Red proteins are FAK binding partners that are implicated in the regulation of the actin cytoskeleton and blue proteins
are FAK binding partners that are implicated in regulating gene expression. Positive (arrows) and negative (bars) regulation of downstream proteins and/or events is
indicated.
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recruitment of Rac1 into a complex with b-pix (Chang et al., 2007).
PKL/Git2 plays a key role in motility by regulating cellular
polarization, stabilizing lamellipodia formation and promoting
direction persistence in migrating cells (Yu et al., 2009). Tyrosine
phosphorylation of PKL/Git2 is required for these functions, and
FAK and Src have been implicated as the responsible kinases (Yu
et al., 2009). These findings demonstrate additional mechanisms
through which FAK can function in the regulation of Cdc42 and
Rac activity to control cellular polarization, the extension of
lamellipodia and cell migration (Fig. 2).
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FAK regulation of the cytoskeleton through other
mechanisms

N-WASP (neuronal Wiskott-Aldrich syndrome protein), which
functions to activate the Arp2/3 complex to promote both actin
branching and nucleation of F-actin assembly, associates with, and
is tyrosine phosphorylated by, FAK (Wu et al., 2004). Whereas FAK
phosphorylation has little effect on N-WASP activity in an in vitro
actin polymerization assay, this observation is interesting in light
of the role of FAK in regulating lamellipodia projection (Fig. 2).
It is also intriguing that FAK can directly associate with the Arp2/3
complex (Serrels et al., 2007) (Fig. 3). This complex appears to be
restricted to the leading edge of cells and is not found in focal
adhesions. Furthermore, the Arp2/3 complex fails to bind to
autophosphorylated FAK, suggesting it is released from FAK upon
its activation (Serrels et al., 2007). These two independent
observations raise the possibility that one function of FAK might
be the recruitment of Arp2/3 to the leading edge and the coordinated
activation of FAK, release of the Arp2/3 complex and the activation
of a key regulator of Arp2/3 activity to promote lamellipodia
formation. This mechanism is highly speculative and further studies
are clearly required to fully test the hypothesis.
A noncatalytic mechanism of regulation of the strength of cellmatrix adhesion by FAK was recently proposed. This mechanism
involves Nudel, a dynein-associated protein that is linked to the
regulation of membrane trafficking, mitosis and cell migration
(Liang et al., 2004; Liang et al., 2007; Shen et al., 2008). Nudel
binds to, and co-localizes with, paxillin at the leading edge of the
cell in nascent adhesions, but not in focal complexes and adhesions
(Shan et al., 2009) (Fig. 3). Interestingly, Nudel binds to the LIMdomain-containing C terminus of paxillin, the region of the protein
that is required for focal-adhesion localization (Brown et al., 1996).
Artificial targeting of Nudel to focal adhesions by the creation of
a paxillin-Nudel chimeric protein produces large focal adhesions
and increases cell adhesion to the ECM. The binding of FAK to
N-terminal LD motifs of paxillin somehow displaces Nudel from
the C terminus of paxillin. Although the molecular mechanism of
displacement is not clear, this is proposed as a mechanism to
modulate the adhesiveness of cell-matrix adhesions as they form
at the leading edge of the cell and mature (Shan et al., 2009).
The emerging theme from studies examining the control of cell
migration by FAK is that multiple downstream targets are involved
in regulating cytoskeletal responses (Fig. 3). This is not surprising,
but it does present the next challenge in the discovery of the
mechanisms of FAK-dependent regulation of cell motility. The
questions of whether different mechanisms are dominant in specific
situations and how different signaling events might be coordinated
remain to be addressed. Furthermore, additional mechanisms
controlling the temporal and spatial regulation of these different
downstream signaling events will undoubtedly become the focus
of future mechanistic studies.

FAK, mechanosensation, migration and
proliferation
In addition to its role in regulating cell migration, FAK regulates
cell proliferation through a number of mechanisms that impinge on
central cell-cycle regulatory molecules (Cox et al., 2006). For
example, FAK promotes expression of cyclin D1 and can control
the levels of p27Kip1 and p21Cip1, in part by controlling SKP2dependent ubiquitination and degradation. FAK also responds to
mechanical stimulation, for example, becoming activated in
endothelial cells in response to shear stress and mechanical stretch
(Vadali et al., 2007). Recent studies have implicated FAK in
controlling changes in migration and proliferation in response to
mechanical stimulation. Fibroblasts sense the stiffness of an
underlying ECM and, at a boundary of stiff and soft matrix, they
migrate onto the stiff matrix. Fibroblasts that lack FAK fail to sense
the difference in stiffness and these cells continue to migrate
indiscriminately onto softer or stiffer matrices (Wang et al., 2001).
Cancer cells respond to the stiffness of the ECM to produce
invadopodia for invasion into the matrix and FAK has been
implicated in this response (Alexander et al., 2008). In threedimensional matrices, the proliferation of both fibroblasts and
epithelial-derived cells depends on the stiffness of the ECM.
Proliferation is low in soft matrix and high in stiff matrix. In the
absence of FAK, both cell types exhibit defects in proliferation in
stiff matrices (Klein et al., 2009; Provenzano et al., 2009). These
observations might be physiologically and/or pathologically
relevant, as injuries that promote proliferative responses cause
increases in tissue stiffness (Klein et al., 2009).
FAK kinases, cadherins and cell-cell junctions
In addition to its well-established role in cell-ECM signaling events,
a role for FAK in regulating cell-cell junctions has emerged. FAK
has been implicated in Src-induced epithelial-mesenchymal
transition (EMT), a process that involves dissolution of cell-cell
junctions, loss of epithelial markers and gain of mesenchymal
markers. Expression of a FAK mutant in this model results
in increased surface expression of E-cadherin and an increase in
E-cadherin-based junction-like structures during a calcium switch
(i.e. when cells are switched to a high-calcium-containing medium)
(Avizienyte et al., 2002). In a transforming growth factor-b (TGFb)induced model of EMT, inhibition of FAK using a dominantnegative approach seems to impair loss of E-cadherin from the cell
surface (Cicchini et al., 2008). These findings are consistent with
a role for FAK in regulating the disassembly of E-cadherin-based
junctions and internalization of E-cadherin. In contrast to these
findings, however, FAK has been implicated in promoting efficient
cell-cell junction formation. Inhibition of FAK by short interfering
RNA (siRNA) in HeLa cells retarded N-cadherin-dependent cellcell junction formation; this impaired junction formation was
attributed to elevated Rac activity in the absence of FAK (Yano
et al., 2004). Similarly, a role for FAK in promoting E-cadherindependent cell-cell junction formation in NBT-II cells was
established using a number of approaches to perturb FAK signaling;
however, in this case, impaired junction formation was apparently
due to elevated Rho activity in the absence of FAK (Playford et al.,
2008). These discordant results are yet to be reconciled, but it seems
apparent that, in different contexts, FAK signaling can elicit
different outcomes at cell-cell junctions. Additional factors
impacting these outcomes are yet to be identified.
Pyk2 has also been implicated in regulating cell-cell junctions.
In endothelial cells, Pyk2 can control disassembly of vascular
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endothelial (VE)-cadherin-mediated cell-cell junctions. Two
different mechanisms have been reported that appear to operate in
response to different stimuli. VE-cadherin antibodies can induce a
signaling event through Rac that results in the production of reactive
oxygen species, Pyk2 activation and phosphorylation of b-catenin
(van Buul et al., 2005); this leads to dissolution of VE-cadherin
junctions. Endothelial-cell Pyk2 also functions in facilitating
transendothelial migration of leukocytes (Allingham et al., 2007).
Engagement of cell-surface intercellular adhesion molecule 1
(ICAM-1) results in activation of Pyk2, but the key event in this
scenario is phosphorylation of the cytoplasmic tail of VE-cadherin
(Allingham et al., 2007). In each case, the consequence is presumed
to be abrogation of the VE-cadherin–b-catenin complex. Why
different Pyk2 targets might be selected in response to different
stimuli remains unclear.
In addition to regulating proximal signaling events that control
cell-cell junction assembly and disassembly, FAK and Pyk2 might
also contribute to alterations in cell-cell junctions by means of an
indirect mechanism, that is, by regulating expression of N-cadherin.
Upon attachment to collagen I, N-cadherin expression is upregulated
at the protein level, cell-cell adhesion is reduced and cells scatter.
Two collagen receptors, the a2b1 integrin and DDR1 (discoidin
domain receptor 1), regulate the activation of FAK and Pyk2,
respectively (Shintani et al., 2008). Both signaling pathways
contribute to elevation of N-cadherin protein expression and the
change in cellular phenotype. Although it is clear that p130cas and
Rap1 function downstream of FAK and Pyk2 to promote N-cadherin
expression and cell scattering (Shintani et al., 2008), the mechanism
regulating N-cadherin protein levels remains to be established.
FAK and microtubules
There is a slowly emerging and intriguing link between FAK and
microtubules (Fig. 2). When dynamic microtubules make contact,
focal adhesions disassemble and FAK plays a role in this process
(Ezratty et al., 2005). This is not surprising given the role of FAK
as a regulator of focal-adhesion disassembly; however, the
mechanism is unexpected. Phosphorylation of tyrosine 925 and
the subsequent recruitment of Grb2 and dynamin into a complex
with FAK are required for microtubule-induced disassembly of focal
adhesions (Ezratty et al., 2005). A more surprising finding is the
link between FAK and the regulation of microtubule structure and
organization. In cells lacking FAK or expressing dominant-negative
FAK mutants, microtubules exhibit defects in tyrosination and
acetylation, two post-translational modifications that are associated
with stabilization of microtubules (Palazzo et al., 2004). FAK is
proposed to modulate the organization of lipid rafts to promote mDia
signaling and microtubule stabilization. Interestingly, Pyk2-null
osteoclasts are defective for bone resorption owing to a defect in
the formation of podosomes and the sealing zone abutting the
underlying bone (Gil-Henn et al., 2007). Microtubules play a role
in the organization of podosomes in osteoclasts and Pyk2-null cells
exhibit a defect in stabilization of microtubules (Gil-Henn et al.,
2007). Thus, Pyk2 also appears to control stabilization of
microtubules. Although the mechanism remains to be established,
levels of Rho activity are elevated in the absence of Pyk2 and
aberrant regulation of Rho is implicated in the perturbation of
microtubule stabilization in osteoclasts (Gil-Henn et al., 2007). In
this regard, there are some parallels between microtubule stability
and aberrant Rho activity in FAK-null fibroblasts and Pyk2-null
osteoclasts, although the precise mechanistic details are yet to
emerge.
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FAK also seems to function at the microtubule-organizing center
(MTOC) (Fig. 2). This was first observed in neurons, where FAK
was identified as a substrate for phosphorylation by Cdk5 (Xie
et al., 2003). Serine 732 in the C-terminal domain of FAK is the
site of phosphorylation and the phosphorylated form of FAK
colocalizes with g-tubulin in the perinuclear region of the cell, that
is, at the MTOC. A mutant defective for phosphorylation localizes
strongly to the MTOC, suggesting that phosphorylation is important
for movement of FAK away from the MTOC. The mutant functions
in a dominant-negative manner and perturbs the organization of the
microtubules at the MTOC (Xie et al., 2003). FAK might also play
a role in organizing the MTOCs in mitotic endothelial cells. FAKnull endothelial cells exhibit mitotic defects, specifically, alterations
in the mitotic spindle and centrosome organization (Park et al.,
2009). The defects are rescued by re-expression of wild-type FAK,
but not by a mutant defective for phosphorylation at serine 732. As
in neurons, Cdk5 regulates phosphorylation of FAK at serine 732
and the phosphorylated form of FAK co-localizes with g-tubulin at
the centrosome (Park et al., 2009). Phosphorylation of serine 732
seems to regulate the association of FAK with dynein in the mitotic
centrosome. These studies clearly link FAK and Pyk2 to the
regulation of microtubule structure and function, which in turn
controls biologically significant events. Although some insight into
mechanism has been gained, this is an underdeveloped area of
investigation that warrants additional studies.
FAK functions in the nucleus
Initial reports first suggested a nuclear function for FAK when
N-terminal fragments of FAK were found to localize in the nucleus
(Jones et al., 2001; Lobo and Zachary, 2000). Additional studies
revealed that full-length FAK and Pyk2 could localize to the nucleus
under appropriate conditions and in a number of different cell types
(Aoto et al., 2002; Yi et al., 2003). Recent evidence has shed some
light on the mechanisms regulating nuclear localization and nuclear
function. Consistent with the initial finding that the N-terminal
domain of FAK could be found in the nucleus, basic sequences
within the N-terminal FERM domain have been implicated as a
nuclear localization signal in FAK (Lim et al., 2008a) (Fig. 1).
However, both full-length FAK and the C-terminal domain of FAK
can be localized to the nucleus in cardiomyocytes (Yi et al., 2003).
This implies an alternative mechanism because the C-terminal
domain lacks the N-terminal nuclear localization sequences, but a
potential mechanism has not been defined. Export from the nucleus
might be regulated by two nuclear export sequences, one of which
lies in the N-terminal FERM domain and the other in the catalytic
domain (Ossovskaya et al., 2008) (Fig. 1).
Recent studies suggest multiple important nuclear functions for
FAK. Two groups provide evidence that FAK functions to impair
transcription of p53-dependent genes (Golubovskaya et al., 2005;
Lim et al., 2008a). This is mediated by FAK binding to p53 in the
nucleus, potentially resulting in attenuation of its transactivating
potential (Golubovskaya et al., 2005). FAK also regulates nuclear
p53 through a second mechanism by scaffolding the p53-MDM2
complex, leading to p53 ubiquitination and degradation (Lim et al.,
2008a) (Fig. 3). These results support a role for FAK in controlling
the expression of specific genes, but there is also evidence that FAK
regulates gene expression at a more global level by controlling
chromatin structure. Nuclear FAK binds to MBD2 (methyl CpGbinding protein 2) (Fig. 3), which binds methylated DNA sequences
to coordinate acetylation and changes in chromatin structure (Luo
et al., 2009). FAK binding reduces histone deacetylase 1 (HDAC1)
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binding to MBD2, which might be important for inducing myogenin
expression in differentiating muscle cells. It is also interesting to
note that FAK is required for the expression of genes that encode
mesenchymal markers in the TGFb-induced EMT model described
above, although no mechanistic details are available (Cicchini
et al., 2008). These findings implicate FAK in regulating gene
expression by more direct mechanisms than originally expected
(Fig. 2) and will provide the impetus for studies to identify FAKregulated genes, which are beginning to appear in the literature
(Golubovskaya et al., 2009b; Provenzano et al., 2008).
Concluding remarks
FAK and Pyk2 are the focus of attention of many laboratories that
are trying to determine how FAK and Pyk2 regulate the actin
cytoskeleton, particularly through Rho family GTPases. As outlined
above, these efforts have yielded strong evidence supporting
multiple molecular mechanisms that link FAK and Pyk2 to Rho
family signaling. Presented individually, they appear as competing
means to accomplish the same goal. Unique responses to different
stimuli or differential spatial and temporal regulation of each
signaling event might provide one reason for the evolution of
different mechanisms of regulation. Alternatively, these different
downstream signaling molecules might provide nodes for input from
other signaling pathways, allowing enhancement or dampening of
FAK-dependent signals based on other stimuli experienced by
the cell.
Provocative new studies have also emerged that solidify roles
for FAK in controlling microtubules and in the nucleus. Studies of
nuclear FAK have now established functional relevance for its
observed localization in the nucleus. Whether these functions of
FAK are universal and as important as its established role in the
regulation of the actin cytoskeleton remain to be established, but
they are certainly novel areas of focus for future investigation.
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